Citations

Showing 10 of 108104 citations.

Recommendations for the Nomenclature of Cognitive Change Associated With Anaesthesia and Surgery—2018
Silbert, Brendan , DeKosky, Steven T. , Rasmussen, Lars S. , Crosby, G., Schenning, Katie J. , Evered, Lisbeth Anne , Knopman, David S. , Scott, David A. , Oh, Esther S , Berger, Miles , Eckenhoff, Roderic G.

Mayo Clinic

Anesthesia & Analgesia | October 16, 2018 | Volume: 127 | Issue: 5 | Pages: 1189-1195

10.1213/ane.0000000000003634 | PMID 30325748 Get It

Cognitive change affecting patients after anaesthesia and surgery has been recognised for more than 100 yr. Research into cognitive change after anaesthesia and surgery accelerated in the 1980s when multiple studies utilised detailed neuropsychological testing for assessment of cognitive change after cardiac surgery. This body of work consistently documented decline in cognitive function in elderly patients after anaesthesia and surgery, and cognitive changes have been identified up to 7.5 yr afterwards. Importantly, other studies have identified that the incidence of cognitive change is similar after non-cardiac surgery. Other than the inclusion of non-surgical control groups to calculate postoperative cognitive dysfunction, research into these cognitive changes in the perioperative period has been undertaken in isolation from cognitive studies in the general population. The aim of this work is to develop similar terminology to that used in cognitive classifications of the general population for use in investigations of cognitive changes after anaesthesia and surgery. A multispecialty working group followed a modified Delphi procedure with no prespecified number of rounds comprised of three face-to-face meetings followed by online editing of draft versions. Two major classification guidelines [Diagnostic and Statistical Manual for Mental Disorders, fifth edition (DSM-5) and National Institute for Aging and the Alzheimer Association (NIA-AA)] are used outside of anaesthesia and surgery, and may be useful for inclusion of biomarkers in research. For clinical purposes, it is recommended to use the DSM-5 nomenclature. The working group recommends that ‘perioperative neurocognitive disorders’ be used as an overarching term for cognitive impairment identified in the preoperative or postoperative period. This includes cognitive decline diagnosed before operation (described as neurocognitive disorder ); any form of acute event ( postoperative delirium ) and cognitive decline diagnosed up to 30 days after the procedure ( delayed neurocognitive recovery ) and up to 12 months ( postoperative neurocognitive disorder ).
Vancomycin elution kinetics from porous tantalum metal
Sautet, Pierre, Mékidèche, Thibaut, Guilhaumou, Romain , Parratte, Sébastien , Ollivier, Matthieu , Abdel, Matthew P. , Argenson, Jean‐Noël

Mayo Clinic

Journal of Orthopaedic Research | October 16, 2018 | Volume: 37 | Issue: 2 | Pages: 308-312

10.1002/jor.24160 | PMID 30325073 Get It

ABSTRACTRevisions TKAs are being completed with uncemented constructs more frequently. We hypothesized that tantalum cones could be an efficient carrier of antibiotics in uncemented procedures. We aimed to compare the release of vancomycin between (i) tantalum and smooth stainless cylinders; (ii) different concentrations of vancomycin; and (iii) different durations of bathing. Specifically designed tantalum cylinders were bathed in a vancomycin solution with various durations of baths. We investigated rinses between each interval as well as the dose of vancomycin. Vancomycin concentrations were determined in each group by fluorescence polarization immunoassay at different intervals (1 h, days 1, 2, 3, 5). At 1 h, the mean vancomycin concentration for the 1‐hour soaking group was 3,172 μg/ml, whereas mean concentration for the smooth stainless steel group was 39.37 μg/ml (p < 0.001). The rinsing group showed a significantly lower concentration at 1 h and 1 day (p < 0.05). The 2‐gram vancomycin group showed no difference at days 1, 2, and 3 compared to the 1‐hour group. The 5, 15, and 30‐minute bathing groups showed significantly lower vancomycin concentrations at all‐time points. All vancomycin concentrations at day 3 were superior to the minimal inhibitory concentration of Staphyloccocus aureus. The mean concentration of vancomycin depends on the material, duration of bathing, the rinsing effect, and the drug dose. Our in‐vitro study is the first to show that porous tantalum cylinders allow antibiotic carriage and progressive release. If appearing in vivo, in a similar extent, this intrinsic property might be useful to prevent and/or treat peri‐prosthetic joint infection. © 2018 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 37:308–312, 2019.
Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing Cholangitis
Tietz-Bogert, Pamela S., Kim, Minsuk , Cheung, Angela , Tabibian, James H. , Rosen, Charles B. , Nandakumar, Madhumitha , Sung, Jaeyun , O’Hara, Steven P. , Lazaridis, Konstantinos N. , Sung, Jaeyun , Tabibian, James H , Kim, Minsuk , Heimbach, Julie K. , LaRusso, Nicholas F.

Mayo Clinic

International Journal of Molecular Sciences | October 16, 2018 | Volume: 19 | Issue: 10 | Pages: 3188

10.3390/ijms19103188 | PMID 30332763 Get It

Primary sclerosing cholangitis (PSC) is a pathogenically complex, chronic, fibroinflammatory disorder of the bile ducts without known etiology or effective pharmacotherapy. Emerging in vitro and in vivo evidence support fundamental pathophysiologic mechanisms in PSC centered on enterohepatic circulation. To date, no studies have specifically interrogated the chemical footprint of enterohepatic circulation in PSC. Herein, we evaluated the metabolome and lipidome of portal venous blood and bile obtained at the time of liver transplantation in patients with PSC (n = 7) as compared to individuals with noncholestatic, end-stage liver disease (viral, metabolic, etc. (disease control, DC, n = 19)) and to nondisease controls (NC, living donors, n = 12). Global metabolomic and lipidomic profiling was performed on serum derived from portal venous blood (portal serum) and bile using ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) and differential mobility spectroscopy-mass spectroscopy (DMS-MS; complex lipid platform). The Mann–Whitney U test was used to identify metabolites that significantly differed between groups. Principal-component analysis (PCA) showed significant separation of both PSC and DC from NC for both portal serum and bile. Metabolite set enrichment analysis of portal serum and bile demonstrated that the liver-disease cohorts (PSC and DC) exhibited similar enrichment in several metabolite categories compared to NC. Interestingly, the bile in PSC was uniquely enriched for dipeptide and polyamine metabolites. Finally, analysis of patient-matched portal serum and biliary metabolome revealed that these biological fluids were more homogeneous in PSC than in DC or NC, suggesting aberrant bile formation and enterohepatic circulation. In summary, PSC and DC patients exhibited alterations in several metabolites in portal serum and bile, while PSC patients exhibited a unique bile metabolome. These specific alterations in PSC are amenable to hypothesis testing and, potentially, therapeutic pharmacologic manipulation.
Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery—2018
Silbert, Brendan , DeKosky, Steven T. , Rasmussen, Lars S. , Crosby, G., Berger, Miles , Group, The Nomenclature Consensus Working, Hogan, Kirk J. , Maruff, Paul , Lyketsos, Constantine G. , Price, Catherine C. , Sachdev, Perminder S. , Schenning, Katie J. , Sachdev, Perminder S , Evered, Lisbeth Anne , Knopman, David S. , Scott, David A. , Oh, Esther S , Eckenhoff, Roderic G. , Group, The Nomenclature Consensus Working, Maruff, Paul

Mayo Clinic

Acta Anaesthesiologica Scandinavica | October 16, 2018 | Volume: 62 | Issue: 10 | Pages: 1473-1480

10.1111/aas.13250 | PMID 30325016 Get It

AbstractCognitive change affecting patients after anaesthesia and surgery has been recognised for more than 100 yr. Research into cognitive change after anaesthesia and surgery accelerated in the 1980s when multiple studies utilised detailed neuropsychological testing for assessment of cognitive change after cardiac surgery. This body of work consistently documented decline in cognitive function in elderly patients after anaesthesia and surgery, and cognitive changes have been identified up to 7.5 yr afterwards. Importantly, other studies have identified that the incidence of cognitive change is similar after non‐cardiac surgery. Other than the inclusion of non‐surgical control groups to calculate postoperative cognitive dysfunction, research into these cognitive changes in the perioperative period has been undertaken in isolation from cognitive studies in the general population. The aim of this work is to develop similar terminology to that used in cognitive classifications of the general population for use in investigations of cognitive changes after anaesthesia and surgery. A multispecialty working group followed a modified Delphi procedure with no prespecified number of rounds comprised of three face‐to‐face meetings followed by online editing of draft versions.Two major classification guidelines [Diagnostic and Statistical Manual for Mental Disorders, fifth edition (DSM‐5) and National Institute for Aging and the Alzheimer Association (NIA‐AA)] are used outside of anaesthesia and surgery, and may be useful for inclusion of biomarkers in research. For clinical purposes, it is recommended to use the DSM‐5 nomenclature. The working group recommends that ‘perioperative neurocognitive disorders’ be used as an overarching term for cognitive impairment identified in the preoperative or postoperative period. This includes cognitive decline diagnosed before operation (described as neurocognitive disorder); any form of acute event (postoperative delirium) and cognitive decline diagnosed up to 30 days after the procedure (delayed neurocognitive recovery) and up to 12 months (postoperative neurocognitive disorder).
OP11.10: Neurodevelopmental outcomes in children with congenital lower urinary tract obstruction (LUTO)
Monteiro, Sónia , Voigt, Robert G. , Nassr, Ahmed A. , Yun, Peter S., Braun, Michael , Roth, David R. , Belfort, Michael A. , Cortes, Magda Sanz , Berretta, Massimiliano , Koh, Chester J. , Ruano, Rodrigo

Mayo Clinic

Ultrasound in Obstetrics & Gynecology | October 16, 2018 | Volume: 52 | Issue: S1 | Pages: 98-98

10.1002/uog.19491 Get It

Pain is associated with reduced quality of life and functional status in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Strand, Elin Bolle , Sandvik, Leiv , Helland, Ingrid B. , Abraham, Semhar, Nes, Lise Solberg , Mengshoel, Anne Marit

Mayo Clinic

Scandinavian Journal of Pain | October 16, 2018 | Volume: 19 | Issue: 1 | Pages: 61-72

10.1515/sjpain-2018-0095 | PMID 30325738 Get It

Abstract Background and aims Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is challenging to live with, often accompanied by pervasive fatigue and pain, accompanied by decreased quality of life (QoL) as well as anxiety and/or depression. Associations between higher pain, lower QoL and higher anxiety and depression have been shown in patients with various chronic pain disorders. Few studies have however examined such associations in a sample of patients with ME/CFS. The aims of the current study were to examine the impact of pain levels and compare levels of pain, health related QoL, anxiety and depression between patients with ME/CFS and healthy controls. In addition, the study aimed and to examine these relationships within the patient group only. Methods This is a cross-sectional questionnaire based study comparing 87 well-diagnosed patients with ME/CFS with 94 healthy controls. The De Paul Symptom Questionnaire (DSQ), the Medical Outcomes Study Short-Form Surveys (SF-36) and the Hospital Anxiety and Depression Scale (HADS) were used to examine and compare pain, physical function, QoL, anxiety and depression in patients and healthy controls. Further the pain variables were divided into pain total, pain intensity and a pain frequency score for analyses of the above mentioned variables within the patient group only. Results Significantly higher levels of pain, anxiety and depression, and lower levels of QoL were found in the patient group compared with healthy controls. For the patient group alone, pain was significantly associated with lower QoL in terms of physical functioning, bodily pain, general health functioning, vitality and social functioning capacity. In this patient sample, only frequency of joint pain showed significant difference in psychological variables such as depression and anxiety – depression combined. Conclusions ME/CFS patients differ significantly from healthy controls in pain, health related QoL, anxiety and depression. Pain is significantly associated with reduced QoL and overall a lower level of functioning. The relation between pain and anxiety and depression appears less clear. Implications Pain is for many ME/CFS patients associated with reduced physical functioning and reduced QoL. A thorough pain assessment can therefore be essential for clinicians, and subsequent medical pain treatment combined with good pain coping skills may increase functioning level and QoL for these patients. The link between joint pain and psychological factors should also be focused in clinical practice in terms of mapping and counseling. Pain should be further examined to understand the importance it may have for functioning level as reduced function is a main criteria when diagnosing the patients.
A Case of IgG4-Related Aortitis and Pericarditis: Diagnostic Challenges and Natural History
Weiss, Matthew A., Aubry, Marie‐Christine, Pflederer, Benjamin R. , Weiss, Matthew A., Aubry, Marie-Christine

Mayo Clinic

American Journal of Case Reports | October 16, 2018 | Volume: 19 | Issue: No issue available | Pages: 1232-1236

10.12659/ajcr.910164 | PMID 30323165 Get It

The stem cell market and policy options: a call for clarity
Zarzeczny, Amy , Illes, Judy , Master, Zubin , Robillard, Julie M. , Turner, Leigh , Zettler, Patricia J. , Master, Zubin , Atkins, Harold L. , Kimmelman, Jonathan , Snyder, Jeremy , Caulfield, Timothy

Mayo Clinic

Journal of Law and the Biosciences | October 15, 2018 | Volume: 5 | Issue: 3 | Pages: 743-758

10.1093/jlb/lsy025 | PMID 31143461 Get It

Idiopathic CD4 Lymphocytopenia with Fulminant Pneumocystis jirovecii Pneumonia
Jundt, Michael C., Ayalew, Assefa M., Hartman, Thomas E. , Roden, Anja C. , Koo, Chi Wan

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | October 15, 2018 | Volume: 199 | Issue: 8 | Pages: e35-e36

10.1164/rccm.201802-0267im | PMID 30321488 Get It